Cointime

Geneseeq

company

About

Geneseeq uses NGS technologies to help physicians make meaningful decisions for cancer treatment.

  • 11 - 50

Highlights

Total Funding Amount
¥860M
Funding Rounds
3
Investors
5
Investments
2

Details

Last Funding Type
Series B
Last Funding Money Raised
¥60M
Industries
Biotechnology,Clinical Trials,Health Care,Life Science
Founded date
Jan 1, 2008
Number Of Employee
11 - 50
Operating Status
Active

Established in 2008, Geneseeq is an industry leader in Next-Generation Sequencing (NGS) fully committed to the research and clinical translation of NGS Genetic Sequencing in the field of personalized medicine.
Geneseeq’s world-leading laboratories have successfully passed China’s National Center of Clinical Laboratories(NCCL) External Quality Assessment(EQA), College of American Pathologists(CAP) PT, European Molecular Genetics Quality Network(EMQN) PT, and received 3rd party medical laboratory and clinical PCR amplification laboratory qualifications.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
¥860M
Geneseeq has raised a total of ¥860M in funding over 2 rounds. Their latest funding was raised on Dec 25, 2019 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 25, 2019 Series D ¥800M 2 — — Detail
Jul 21, 2017 Series C — 2 — — Detail
Jun 1, 2016 Series B ¥60M 1 — — Detail

Investments

Number of Investments
Number of Lead Investments
2
0
Geneseeq has made 2 investments. Their most recent investment was on Sep 26, 2014, when MoviePass raised $2.20M.
Date Company Name
Round Money Raised Industry Lead Investor
Sep 26, 2014 MoviePass
Series A $2.20M Apps —
Feb 23, 2011 MoviePass
Seed $1.50M Apps —

Investors

Number of Lead Investors
Number of Investors
—
5
Geneseeq is funded by 5 investors. China Reform Holdings Corporation and Lilly Asia Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
China Reform Holdings Corporation — Series D
Lilly Asia Ventures — Series D
Boyuanhongsheng — Series C
Huatai Health Fund — Series C
Eastern Investment — Series B
Cointime
เนื้อหา
บริษัท